Novavax Receives $384M For Coronavirus Vaccine Program In CEPI's 'Single Biggest Investment' To DateBenzinga • 05/11/20
Novavax to Receive up to $388 Million Funding from CEPI for COVID-19 Vaccine Development and ManufacturingGlobeNewsWire • 05/11/20
Novavax (NVAX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 ReleaseZacks Investment Research • 04/30/20
Novavax to Start Human Clinical Trials for Its Potential Coronavirus Vaccine in MayThe Motley Fool • 04/08/20
Novavax News: NVAX Stock Surges 14% as Human Trial for Coronavirus Vaccine NearsInvestorPlace • 04/08/20